Secondary myelodysplastic syndromes following peripheral blood stem cell transplantation: morphological, cytogenetic and clonality evaluation and the limitation of FAB criteria
- 1 July 2000
- journal article
- other
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 26 (2) , 241-242
- https://doi.org/10.1038/sj.bmt.1702502
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDSBone Marrow Transplantation, 1999
- Predictive Value of Clonality Assays in Patients With Non-Hodgkin's Lymphoma Undergoing Autologous Bone Marrow Transplant: A Single Institution StudyBlood, 1998
- Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemiaAnnals of Hematology, 1997
- Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non- Hodgkin's lymphomaBlood, 1994
- Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasiaBritish Journal of Haematology, 1987